Zentek Ltd (formerly known as ZEN Graphene Solutions and before that, Zenyatta Ventures) is a mineral exploration and development company based in Ontario, Canada. Zentek is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.
The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zentek has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.
According to Zentek, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.
The latest ZEN Graphene news:
Zentek has announced that it will be opening its industrial scale ZenGUARD™ antimicrobial production facility in Guelph, Ontario on June 17th, 2022. This facility is claimed by Zentek to be one of the largest nanomaterials-based manufacturing facilities in the world.
“The opening of this facility is an important milestone for our company as it represents our successful journey from the lab, through regulatory and now to industrial commercialization. I would like to personally thank all our employees and vendor partners who put in considerable time and effort to make this happen,” said Greg Fenton, CEO of Zentek. “We’re now ready to begin meeting the growing interest and demand for our ZenGUARD™ coating.”
Zentek has announced that McMaster University has received two Natural Sciences and Engineering Research Council (“NSERC”) Grants related to the aptamer-based rapid detection technology exclusively licensed by Zentek, pursuant to its license agreement with McMaster: The Alliance Missions Grant for the amount of CAD$1,000,000 (around USD$782,000) and an Idea to Innovation (I2I) Grant for the amount of CAD$350,000 (around USD$274,000) of which Zentek will make a CAD$140,000 (around USD$109,000) contribution. Both of these awards are the maximum awarded under each respective grant program, with disbursements delivered over the next two years.
“The research team at McMaster University has achieved significant milestones for the rapid diagnostic platform including the creation of a new ‘universal’ aptamer with a high binding affinity to all known Covid variants,” said Greg Fenton, CEO of Zentek. “Zentek is proud to continue working with the global-leading research team at McMaster University, with significant financial support from NSERC, which is a great endorsement of our technology and goal of commercialization.”
Zentek has announced it has signed a definitive supply agreement with EkoMed Global, a globally integrated manufacturer and distributor of personal protective equipment (“PPE”), according to which Zentek will sell quantities of its proprietary ZenGUARD™ coating to EkoMed for use on EkoMed’s surgical masks and potentially other PPE in the future. The agreement also stipulates that Zentek will purchase surgical masks manufactured by EkoMed, to be treated with ZenGUARD™ coating and resold by Zentek.
“This agreement solidifies our relationship with an established and highly competitive player in the PPE space and a potential future innovation partner; both key elements of our global ZenGUARD™ sales strategy,” said Greg Fenton, CEO of Zentek. “As we seek to gain access to new markets, reliable, high-capacity and high-quality production along with additional sales channels for our patent-pending ZenGUARD™ technology are crucial. We believe this agreement will establish a solid foundation for Zentek to expand access to ZenGUARD™ globally. As important, we look forward to working with the EkoMed team to explore incorporating ZenGUARD™ into other PPE products currently being manufacturing and commercialized by EkoMed.”
Zentek has announced the patent-pending development of a graphene-wrapped silicon anode material, developed along with Prof. Michael Pope, an Associate Professor in the Department of Chemical Engineering at the University of Waterloo, and in collaboration Dr. Marianna Uceda and Dr. Zimin She.
Zentek’s CEO, Greg Fenton, commented: “We are very pleased to support Dr. Pope and his group at the University of Waterloo. Their innovation has the potential to improve the current lithium-ion battery by upgrading graphite to this graphene-wrapped silicon anode. Not only were the researchers able to demonstrate good performance with laboratory-scale half-cells, the performance was also validated with commercial lithium iron phosphate cathodes suggesting they could be a drop-in solution for enhancing already available battery technologies. We look forward to continuing our support of their research and development to potentially bring this technology to market. The company has begun discussions with a potential industry partner.”
Zentek has announced that it has entered into a binding letter of intent with GMAF Circular Medico ApS (“GMAF”) to produce and sell ZENGuard™-enhanced GMAF trademarked recyclable surgical masks (“Circular PPE”).
Zentek’s Medical Device Establishment License (“MDEL”) allows the Company to work with other manufacturers and distributors around the world to sell Class I PPE products in the Canadian market. Pursuant to the terms of the LOI, ZEN and GMAF have agreed to negotiate a definitive agreement to bring Circular PPETM coated with ZENGuard™ to the Canadian market while also evaluating regulatory requirements in other target markets. Commercial sales of Circular PPETM with ZENGuard™ outside of Canada will be subject to applicable regulatory approvals.